These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 9816108

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Epidermal growth factor receptor vIII enhances tumorigenicity in human breast cancer.
    Tang CK, Gong XQ, Moscatello DK, Wong AJ, Lippman ME.
    Cancer Res; 2000 Jun 01; 60(11):3081-7. PubMed ID: 10850460
    [Abstract] [Full Text] [Related]

  • 23. Compensatory stabilization of RIIbeta protein, cell cycle deregulation, and growth arrest in colon and prostate carcinoma cells by antisense-directed down-regulation of protein kinase A RIalpha protein.
    Nesterova M, Noguchi K, Park YG, Lee YN, Cho-Chung YS.
    Clin Cancer Res; 2000 Sep 01; 6(9):3434-41. PubMed ID: 10999726
    [Abstract] [Full Text] [Related]

  • 24. Differential interactions between IGFBP-3 and transforming growth factor-beta (TGF-beta) in normal vs cancerous breast epithelial cells.
    McCaig C, Fowler CA, Laurence NJ, Lai T, Savage PB, Holly JM, Perks CM.
    Br J Cancer; 2002 Jun 17; 86(12):1963-9. PubMed ID: 12085194
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Down-regulation of RI alpha subunit of cAMP-dependent protein kinase induces growth inhibition of human mammary epithelial cells transformed by c-Ha-ras and c-erbB-2 proto-oncogenes.
    Ciardiello F, Pepe S, Bianco C, Baldassarre G, Ruggiero A, Bianco C, Selvam MP, Bianco AR, Tortora G.
    Int J Cancer; 1993 Feb 01; 53(3):438-43. PubMed ID: 8094073
    [Abstract] [Full Text] [Related]

  • 27. Overexpression of sialomucin complex, a rat homologue of MUC4, inhibits tumor killing by lymphokine-activated killer cells.
    Komatsu M, Yee L, Carraway KL.
    Cancer Res; 1999 May 01; 59(9):2229-36. PubMed ID: 10232613
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Scanning microphotometry image analysis of Ha-ras-transformed human breast epithelial cells.
    Mello ML, Lin TY, Russo J.
    Anal Cell Pathol; 1994 Dec 01; 7(4):301-19. PubMed ID: 7696155
    [Abstract] [Full Text] [Related]

  • 32. Redirected T-cell cytotoxicity to epithelial cell adhesion molecule-overexpressing adenocarcinomas by a novel recombinant antibody, E3Bi, in vitro and in an animal model.
    Ren-Heidenreich L, Davol PA, Kouttab NM, Elfenbein GJ, Lum LG.
    Cancer; 2004 Mar 01; 100(5):1095-103. PubMed ID: 14983507
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Raf and RhoA cooperate to transform intestinal epithelial cells and induce growth resistance to transforming growth factor beta.
    Du J, Jiang B, Coffey RJ, Barnard J.
    Mol Cancer Res; 2004 Apr 01; 2(4):233-41. PubMed ID: 15140945
    [Abstract] [Full Text] [Related]

  • 35. Protein array technology to detect HER2 (erbB-2)-induced 'cytokine signature' in breast cancer.
    Vazquez-Martin A, Colomer R, Menendez JA.
    Eur J Cancer; 2007 May 01; 43(7):1117-24. PubMed ID: 17379503
    [Abstract] [Full Text] [Related]

  • 36. Acidic pH inhibits non-MHC-restricted killer cell functions.
    Fischer B, Müller B, Fischer KG, Baur N, Kreutz W.
    Clin Immunol; 2000 Sep 01; 96(3):252-63. PubMed ID: 10964544
    [Abstract] [Full Text] [Related]

  • 37. Protein kinase A-Ialpha subunit-directed antisense inhibition of ovarian cancer cell growth: crosstalk with tyrosine kinase signaling pathway.
    Alper O, Hacker NF, Cho-Chung YS.
    Oncogene; 1999 Sep 02; 18(35):4999-5004. PubMed ID: 10490835
    [Abstract] [Full Text] [Related]

  • 38. Augmenting major histocompatibility complex class I expression by murine tumors in vivo enhances antitumor immunity induced by an active immunotherapy strategy.
    Merritt RE, Yamada RE, Crystal RG, Korst RJ.
    J Thorac Cardiovasc Surg; 2004 Feb 02; 127(2):355-64. PubMed ID: 14762342
    [Abstract] [Full Text] [Related]

  • 39. Overexpression and hyperactivity of breast cancer-associated fatty acid synthase (oncogenic antigen-519) is insensitive to normal arachidonic fatty acid-induced suppression in lipogenic tissues but it is selectively inhibited by tumoricidal alpha-linolenic and gamma-linolenic fatty acids: a novel mechanism by which dietary fat can alter mammary tumorigenesis.
    Menendez JA, Ropero S, Mehmi I, Atlas E, Colomer R, Lupu R.
    Int J Oncol; 2004 Jun 02; 24(6):1369-83. PubMed ID: 15138577
    [Abstract] [Full Text] [Related]

  • 40. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells.
    Dong K, Wang R, Wang X, Lin F, Shen JJ, Gao P, Zhang HZ.
    Breast Cancer Res Treat; 2009 Feb 02; 113(3):443-56. PubMed ID: 18327707
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.